Oncolytics Biotech (oncy) Misses Q3 EPS by 25c
Oncolytics Biotech (NASDAQ: oncy) reported Q3 EPS of ($0.02), $0.25 worse than the analyst estimate of $0.23.
For earnings history and earnings-related data on Oncolytics Biotech (oncy) click here.
Oncolytics Biotech (NASDAQ: oncy) reported Q3 EPS of ($0.02), $0.25 worse than the analyst estimate of $0.23.
For earnings history and earnings-related data on Oncolytics Biotech (oncy) click here.